Previous 10 | Next 10 |
home / stock / adtx / adtx articles
Gainers OpGen, Inc. (NASDAQ: OPGN) jumped 593% to $2.33 following two SEC filings from the precision medicine company. The company has received a...
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing...
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and st...
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Friday. The Dow traded up 0.15% to 34,774.75 whi...
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) surged 181.1% to $3.63. TradeUP Acquisition Corp. (NASDAQ: UPTD) gained 148.5% to $18.14. Tao...
U.S. stocks traded mostly lower midway through trading, following the release of jobs data. The Dow traded up 0.03% to 34,732.89 while the NAS...
Aditxt, Inc. (NASDAQ: ADTX)shares are trading lower Friday after the company announced a $10 million private placement priced at-the-market under N...
U.S. stocks traded higher this morning, following the release of jobs data. Following the market opening Friday, the Dow traded up 0.65% to 34,948....
Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) rose 53.4% to $0.2147 in pre-market trading after the company announced it received an Under...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...